Myhlth Chck Share Price (MHC)

Definitely no point in existing holders bailing unless you’re happy to materialise loses. It’s definitely going to be interesting to listen to the board meeting.

It will interesting to see if any asks about the board’s intentions to buy at these levels!.

I personally feel the best opportunity for MHC would be if the Pharmacy first was extended to include More tests that include MHC products but that is more of a wishful thinking at this point.

I do feel Covid revenue will be ongoing at lower levels but MHC need to show growth in new tests to convince the market. Its current valuations warranted based on competition companies who have survived by dilution etc such as ABDX.

These results were no surprise however they have cash to survive so I’m interested in a plan. The survival and expansion will need growth in new tests 100%. The time has come for the board to show leadership and a meaningful investor’s meeting is required. I’m not disappointed by the lack of a dividend however would have thought a buyback inevitable given the share price!. Maybe given they have left it so long to issue results up to 31st December they may have something else to announce when first half figures announced. They have prepared us for a Covid slowdown however all eyes on new products.

Most investors over 80-90% down you have to sit tight in my opinion.

The positive is they shouldn’t need any cash raises however the revenue growth must be shown.

Agree, total sales of new tests of about £344k for the year on a turnover of £11m is a tiny amount and exposes a serious risk to viability if the covid revenues drop off any more. It felt like a missed opportunity to set out more about the way ahead, beyond that it can be funded from existing cash balances, whatever it is. Without something more solid on the fact there is cash in the bank feels like there is no plan and suspect the SP reflects that sentiment if seen the same way by others.

It feels like MHC is in a bit of a holding pattern with either a dive because covid income drys up and cash burn will eat the reserves within 18-24 months based on current income / profit from new tests or more of the same with no news as there is nothing to update shareholders or the market on as there is no plan. The only other alternative I can think of is trying to make MHC appeal to a buyout or takeover. With a market cap below cash in the bank the SP seems low but with the lack of vision being shown I can understand why it is where it is.

Holding for now as sitting on too big a loss to make it worth bailing out!

45% increase of not a lot is erm,... Not a lot!!

Smudge

It appears the new tests are gaining traction however it appears a bit vague on things. We all it will take time but I personally feel we can not depend too n Boots alone. Whilst it’s a great strategy and valuable moving forward we must realise Boots have no loyalty demonstrated by the recent contracts with ABDX.

The cash could be used to expand into other main stream retailers,Gyms for weight management tests and vitamin tests etc. Also expand into Tik Tok shop etc. Maybe they will offer something later.

These results are what most anticipated and it’s positive to see new tests appear to be gaining traction however it’s a challenge to get them noticed as a change from normal habits of calling a GP.

Still we must commend them for be self sufficient.

Anyway I’m probably biased towards MHC as do believe they are onto something if they utilise the digital data etc. The problem is how must the digital data costs compared to income derived from it.

Stay positive

Revenue halving from 22 million to 11 million is the biggest issue here. That is a substantial worry IMO.

Cash is strong which is a positive, but how long is that going to hold up on those levels of revenue decline.

They have been playing the 'self-funded for next phase of growth ' card for too long. They need someone capable of leading that transition, they can't just have their eggs in one basket (Boots).